Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomics of Myeloproliferative Neoplasms.
Zoi K, Cross NC. Zoi K, et al. Among authors: cross nc. J Clin Oncol. 2017 Mar 20;35(9):947-954. doi: 10.1200/JCO.2016.70.7968. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28297629 Review.
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NC. Jones AV, et al. Among authors: cross nc. Blood. 2005 Sep 15;106(6):2162-8. doi: 10.1182/blood-2005-03-1320. Epub 2005 May 26. Blood. 2005. PMID: 15920007 Free article.
No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage.
Dahabreh IJ, Jones AV, Voulgarelis M, Giannouli S, Zoi C, Alafakis-Tzannatos C, Varla-Leftherioti M, Moutsopoulos HM, Loukopoulos D, Fotiou S, Cross NC, Zoi K. Dahabreh IJ, et al. Among authors: cross nc. Br J Haematol. 2009 Mar;144(5):802-3. doi: 10.1111/j.1365-2141.2008.07510.x. Epub 2008 Nov 17. Br J Haematol. 2009. PMID: 19036091 Free article. No abstract available.
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms.
Jones AV, Campbell PJ, Beer PA, Schnittger S, Vannucchi AM, Zoi K, Percy MJ, McMullin MF, Scott LM, Tapper W, Silver RT, Oscier D, Harrison CN, Grallert H, Kisialiou A, Strike P, Chase AJ, Green AR, Cross NC. Jones AV, et al. Among authors: cross nc. Blood. 2010 Jun 3;115(22):4517-23. doi: 10.1182/blood-2009-08-236448. Epub 2010 Mar 19. Blood. 2010. PMID: 20304805 Free PMC article. Clinical Trial.
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Ernst T, Chase A, Zoi K, Waghorn K, Hidalgo-Curtis C, Score J, Jones A, Grand F, Reiter A, Hochhaus A, Cross NC. Ernst T, et al. Among authors: cross nc. Haematologica. 2010 Sep;95(9):1473-80. doi: 10.3324/haematol.2010.021808. Epub 2010 Apr 26. Haematologica. 2010. PMID: 20421268 Free PMC article.
413 results